Skip to main content

Table 1 Baseline characteristics of eligible patients

From: Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial

 

Baicalin (n = 166)

Placebo (n = 165)

P value

Age (years)

51.3 ± 4.2

52.1 ± 5.8

> 0.05

Gender (male/female)

74/92

67/98

> 0.05

BMI (kg/m2)

25.9 ± 4.1

26.3 ± 3.7

> 0.05

Smoking (n)

49

57

> 0.05

SBP (mmHg)

143.7 ± 7.6

148.2 ± 6.3

> 0.05

DBP (mmHg)

86.1 ± 8.3

89.4 ± 7.8

> 0.05

Time of RA diagnosis (years)

5.1 ± 2.4

5.8 ± 2.9

> 0.05

  1. Values are mean ± SD. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure